Methodological challenges in biomedical HIV prevention trials /
Methodological challenges in biomedical HIV prevention trials /
Committee on the Methodological Challenges in HIV Prevention Trials, Board on Global Health ; Stephen W. Lagakos and Alicia R. Gable, editors ; Institute of Medicine of the National Academies.
- Washington, D.C. : National Academies Press, c2008.
- xi, 258 p. : ill. ; 23 cm.
Includes bibliographical references.
"This IOM committee was formed at the request of the Bill & Melinda Gates Foundation and charged with addressing methodological challenges in late-stage nonvaccine biomedical HIV prevention trials with a specific focus on microbicide and pre-exposure prophylaxis trials."
0309114306 (pbk.) 9780309114301 (pbk.)
2008299718
AIDS (Disease)--Prevention.
HIV Infections--prevention & control.
Clinical Trials as Topic.
Program Evaluation--methods.
Anti-Infective Agents--therapeutic use.
Anti-Retroviral Agents--therapeutic use.
RA643.83 / .M48 2008
362.196/9792
Includes bibliographical references.
"This IOM committee was formed at the request of the Bill & Melinda Gates Foundation and charged with addressing methodological challenges in late-stage nonvaccine biomedical HIV prevention trials with a specific focus on microbicide and pre-exposure prophylaxis trials."
0309114306 (pbk.) 9780309114301 (pbk.)
2008299718
AIDS (Disease)--Prevention.
HIV Infections--prevention & control.
Clinical Trials as Topic.
Program Evaluation--methods.
Anti-Infective Agents--therapeutic use.
Anti-Retroviral Agents--therapeutic use.
RA643.83 / .M48 2008
362.196/9792